Data Validation
Data Validation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Assumptions of Survival Analysis
Strategies for Assessing and Addressing Confounding
Steps in the Modeling Process
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 18, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
L Wynants1, G S Collins2, B Van Calster3
1KU Leuven Department of Electrical Engineering-ESAT, STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven iMinds Medical IT Department, Leuven, Belgium.
This paper outlines ten essential steps for developing robust disease risk models, from initial concept to clinical implementation. It highlights common pitfalls to ensure models are generalizable and useful in practice.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: